MedPath

The Impact of sacubitril/valsartan on atrial fibrillation in hypertensive patients with cardiac implantable electronic devices

Not Applicable
Recruiting
Conditions
Hypertension and Atrial Fibrillation
Registration Number
JPRN-UMIN000049953
Lead Sponsor
Hyogo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with sacubitril/valsartan contraindications, patients with chronic atrial fibrillation, patients with eGFR 30 mL/min/1.73 m2 or less, patients with systolic blood pressure less than 100 mmHg

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath